Concepedia

Publication | Open Access

Real‐world 10‐year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age‐related macular degeneration

DOIFull Paper Access

45

Citations

27

References

2019

Year

Troels Brynskov, Inger Christine Munch, Tobias Malte Larsen, Liv Erngaard, Torben Lykke Sørensen
Acta Ophthalmologica

Abstract

A treatment-as-needed regimen stabilized BCVA in active nAMD up to 10 years in most eyes. Baseline BCVA was the most important prognostic factor.

References

YearCitations

Page 1